Primary care in the time of COVID-19: monitoring the effect of the pandemic and the lockdown measures on 34 quality of care indicators calculated for 288 primary care practices covering about 6 million people in Catalonia

To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality st...

Full description

Saved in:
Bibliographic Details
Published inBMC family practice Vol. 21; no. 1; pp. 208 - 9
Main Authors Coma, Ermengol, Mora, Núria, Méndez, Leonardo, Benítez, Mència, Hermosilla, Eduardo, Fàbregas, Mireia, Fina, Francesc, Mercadé, Albert, Flayeh, Souhel, Guiriguet, Carolina, Balló, Elisabet, Martinez Leon, Nuria, Mas, Ariadna, Cordomí, Sílvia, Lejardi, Yolanda, Medina, Manuel
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 10.10.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator's percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change. We observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of - 2.69% (95%CI - 3.17% to - 2.23%) in March and - 3.41% (95%CI - 3.82% to - 3.01%) in April; and the control of blood pressure with a reduction of - 2.13% (95%CI - 2.34% to - 1.9%) and - 2.59% (95%CI - 2.8% to - 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of - 2.86% (95%CI - 3.33% to - 2.39%) and - 4.13% (95%CI - 4.55% to - 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome. The COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved.
AbstractList To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care.BACKGROUNDTo analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care.Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator's percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change.METHODSRetrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator's percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change.We observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of - 2.69% (95%CI - 3.17% to - 2.23%) in March and - 3.41% (95%CI - 3.82% to - 3.01%) in April; and the control of blood pressure with a reduction of - 2.13% (95%CI - 2.34% to - 1.9%) and - 2.59% (95%CI - 2.8% to - 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of - 2.86% (95%CI - 3.33% to - 2.39%) and - 4.13% (95%CI - 4.55% to - 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome.RESULTSWe observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of - 2.69% (95%CI - 3.17% to - 2.23%) in March and - 3.41% (95%CI - 3.82% to - 3.01%) in April; and the control of blood pressure with a reduction of - 2.13% (95%CI - 2.34% to - 1.9%) and - 2.59% (95%CI - 2.8% to - 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of - 2.86% (95%CI - 3.33% to - 2.39%) and - 4.13% (95%CI - 4.55% to - 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome.The COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved.CONCLUSIONSThe COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved.
To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator's percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change. We observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of - 2.69% (95%CI - 3.17% to - 2.23%) in March and - 3.41% (95%CI - 3.82% to - 3.01%) in April; and the control of blood pressure with a reduction of - 2.13% (95%CI - 2.34% to - 1.9%) and - 2.59% (95%CI - 2.8% to - 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of - 2.86% (95%CI - 3.33% to - 2.39%) and - 4.13% (95%CI - 4.55% to - 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome. The COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved.
Background To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Methods Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator’s percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change. Results We observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of − 2.69% (95%CI − 3.17% to − 2.23%) in March and − 3.41% (95%CI − 3.82% to − 3.01%) in April; and the control of blood pressure with a reduction of − 2.13% (95%CI − 2.34% to − 1.9%) and − 2.59% (95%CI − 2.8% to − 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of − 2.86% (95%CI − 3.33% to − 2.39%) and − 4.13% (95%CI − 4.55% to − 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome. Conclusions The COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved.
To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator's percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change. We observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of - 2.69% (95%CI - 3.17% to - 2.23%) in March and - 3.41% (95%CI - 3.82% to - 3.01%) in April; and the control of blood pressure with a reduction of - 2.13% (95%CI - 2.34% to - 1.9%) and - 2.59% (95%CI - 2.8% to - 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of - 2.86% (95%CI - 3.33% to - 2.39%) and - 4.13% (95%CI - 4.55% to - 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome. The COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved.
Abstract Background To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Methods Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator’s percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change. Results We observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of − 2.69% (95%CI − 3.17% to − 2.23%) in March and − 3.41% (95%CI − 3.82% to − 3.01%) in April; and the control of blood pressure with a reduction of − 2.13% (95%CI − 2.34% to − 1.9%) and − 2.59% (95%CI − 2.8% to − 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of − 2.86% (95%CI − 3.33% to − 2.39%) and − 4.13% (95%CI − 4.55% to − 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome. Conclusions The COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved.
Background To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Methods Retrospective study in 288 primary care practices (PCP) of the Catalan Institute of Health. We analysed the results of 34 indicators of the Healthcare quality standard (EQA), comprising different types: treatment (4), follow-up (5), control (10), screening (7), vaccinations (4) and quaternary prevention (4). For each PCP, we calculated each indicator's percentage of change in February, March and April 2020 respective to the results of the previous month; and used the T-Student test for paired data to compare them with the percentage of change in the same month of the previous year. We defined indicators with a negative effect those with a greater negative change or a lesser positive change in 2020 in comparison to 2019; and indicators with a positive effect those with a greater positive change or a lesser negative change. Results We observed a negative effect on 85% of the EQA indicators in March and 68% in April. 90% of the control indicators had a negative effect, highlighting the control of LDL cholesterol with a reduction of - 2.69% (95%CI - 3.17% to - 2.23%) in March and - 3.41% (95%CI - 3.82% to - 3.01%) in April; and the control of blood pressure with a reduction of - 2.13% (95%CI - 2.34% to - 1.9%) and - 2.59% (95%CI - 2.8% to - 2.37%). The indicators with the greatest negative effect were those of screening, such as the indicator of diabetic foot screening with a negative effect of - 2.86% (95%CI - 3.33% to - 2.39%) and - 4.13% (95%CI - 4.55% to - 3.71%) in March and April, respectively. Only one vaccination indicator, adult Measles-Mumps-Rubella vaccine, had a negative effect in both months. Finally, among the indicators of quaternary prevention, we observed negative effects in March and April although in that case a lower inadequacy that means better clinical outcome. Conclusions The COVID-19 epidemic and the lockdown measures have significantly reduced the results of the follow-up, control, screening and vaccination indicators for patients in primary care. On the other hand, the indicators for quaternary prevention have been strengthened and their results have improved. Keywords: Quality Indicators, Health Care, COVID-19 [Supplementary Concept]., Chronic disease., Quaternary Prevention., Quality Assurance, Health Care., Primary health care.
ArticleNumber 208
Audience Academic
Author Mora, Núria
Flayeh, Souhel
Coma, Ermengol
Lejardi, Yolanda
Benítez, Mència
Medina, Manuel
Méndez, Leonardo
Martinez Leon, Nuria
Fàbregas, Mireia
Mercadé, Albert
Mas, Ariadna
Cordomí, Sílvia
Guiriguet, Carolina
Hermosilla, Eduardo
Fina, Francesc
Balló, Elisabet
Author_xml – sequence: 1
  givenname: Ermengol
  orcidid: 0000-0001-8000-3321
  surname: Coma
  fullname: Coma, Ermengol
– sequence: 2
  givenname: Núria
  surname: Mora
  fullname: Mora, Núria
– sequence: 3
  givenname: Leonardo
  surname: Méndez
  fullname: Méndez, Leonardo
– sequence: 4
  givenname: Mència
  surname: Benítez
  fullname: Benítez, Mència
– sequence: 5
  givenname: Eduardo
  surname: Hermosilla
  fullname: Hermosilla, Eduardo
– sequence: 6
  givenname: Mireia
  surname: Fàbregas
  fullname: Fàbregas, Mireia
– sequence: 7
  givenname: Francesc
  surname: Fina
  fullname: Fina, Francesc
– sequence: 8
  givenname: Albert
  surname: Mercadé
  fullname: Mercadé, Albert
– sequence: 9
  givenname: Souhel
  surname: Flayeh
  fullname: Flayeh, Souhel
– sequence: 10
  givenname: Carolina
  surname: Guiriguet
  fullname: Guiriguet, Carolina
– sequence: 11
  givenname: Elisabet
  surname: Balló
  fullname: Balló, Elisabet
– sequence: 12
  givenname: Nuria
  surname: Martinez Leon
  fullname: Martinez Leon, Nuria
– sequence: 13
  givenname: Ariadna
  surname: Mas
  fullname: Mas, Ariadna
– sequence: 14
  givenname: Sílvia
  surname: Cordomí
  fullname: Cordomí, Sílvia
– sequence: 15
  givenname: Yolanda
  surname: Lejardi
  fullname: Lejardi, Yolanda
– sequence: 16
  givenname: Manuel
  surname: Medina
  fullname: Medina, Manuel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33038926$$D View this record in MEDLINE/PubMed
BookMark eNp9U8luFDEQbaEgssAPcECWuHDp0LZ7sTkgRcMWKVI4AFerxm1PHNz2xO0OysfyL9T0TNAkQsgH2-VXr16Vq46LgxCDKYqXtDqlVLRvR8pE15QVq8qKsk6U4klxROuOlozJ9mDvfFgcj-N1VdFOMPasOOS84kKy9qj4_TW5AdId0ZAMcYHkK0OyGwyJliwuf5x_KKl8R4YYXI7JhdUMMNYanTeQzW0NoTeD0wT32eCj_tnHX4EMBsYpmZHEQHhNbibwLt9t_HbheqcBeUe8ez15yKYnNibChCDrfWXrBDo7jVQ63ppZCCzjlElLBue9wwBrE9d-zmEBGTwqhufFUwt-NC92-0nx_dPHb4sv5cXl5_PF2UWpm5bnktPW0npJQTApBe07XbVMApXQoLmXgoOlppZW9xJawKr3WD0OXPZV13WUnxTnW94-wrXaCVcRnJoNMa0UJJTvjaK0ZyCW1lgq6oY1oodGt7XV-CB5XSHX-y3XeloOptcm5AT-AenDl-Cu1Creqq6p8Xs3Yt7sCFK8mcyY1eBGbbyHYOI0KlbXUkreihqhrx9Br-OUApYKUQ3tupbRPdQKMAEXbMS4ekOqzlou6lYy2iHq9B8oXHNvYOdah_YHDq_2E_2b4X1zIkBsATrFcUzGKu0yZPxrZHZe0Upt5kBt50DhHKh5DpRAV_bI9Z79P05_AMKZCok
CitedBy_id crossref_primary_10_1097_pq9_0000000000000476
crossref_primary_10_1136_bmjopen_2020_047567
crossref_primary_10_3390_healthcare12141420
crossref_primary_10_1007_s10935_023_00733_3
crossref_primary_10_1177_09720634231195136
crossref_primary_10_33880_ejfm_2023120207
crossref_primary_10_3399_BJGP_2022_0353
crossref_primary_10_1016_j_numecd_2022_07_017
crossref_primary_10_1186_s12875_023_02131_4
crossref_primary_10_2147_CIA_S444716
crossref_primary_10_1186_s12913_023_10209_z
crossref_primary_10_1177_17085381221079108
crossref_primary_10_1016_j_pcd_2023_04_009
crossref_primary_10_3389_fpsyt_2021_624125
crossref_primary_10_3389_fpubh_2022_870314
crossref_primary_10_17116_pain20222004145
crossref_primary_10_1371_journal_pone_0258015
crossref_primary_10_1093_eurpub_ckac107
crossref_primary_10_1097_QMH_0000000000000458
crossref_primary_10_1186_s41983_021_00354_9
crossref_primary_10_1016_j_lanepe_2024_101102
crossref_primary_10_1016_j_aprim_2021_102209
crossref_primary_10_1016_j_semerg_2021_06_006
crossref_primary_10_1097_JXX_0000000000000768
crossref_primary_10_3390_ijerph20043165
crossref_primary_10_1097_PR9_0000000000000899
crossref_primary_10_1186_s12875_020_01326_3
crossref_primary_10_1001_jamahealthforum_2023_0351
crossref_primary_10_1186_s12875_022_01935_0
crossref_primary_10_1080_09513590_2022_2132224
crossref_primary_10_4274_imj_galenos_2023_25589
crossref_primary_10_1089_pop_2021_0211
crossref_primary_10_1016_j_aprim_2021_102217
crossref_primary_10_2147_CLEP_S387461
crossref_primary_10_7189_jogh_14_05020
crossref_primary_10_1371_journal_pone_0277764
crossref_primary_10_1186_s12875_022_01674_2
crossref_primary_10_1016_j_aprim_2023_102778
crossref_primary_10_1093_intqhc_mzac074
crossref_primary_10_1186_s13098_022_00845_6
crossref_primary_10_1016_j_eimce_2023_04_003
crossref_primary_10_1016_j_semerg_2022_04_003
crossref_primary_10_1186_s12875_021_01587_6
crossref_primary_10_1371_journal_pone_0271049
crossref_primary_10_1080_17446651_2021_1927708
crossref_primary_10_1093_eurjcn_zvab120
crossref_primary_10_3390_ijerph20021600
crossref_primary_10_1016_j_healthpol_2021_08_002
crossref_primary_10_1186_s12913_022_08105_z
crossref_primary_10_2196_50728
crossref_primary_10_1016_j_gaceta_2022_03_003
crossref_primary_10_1186_s12875_022_01792_x
crossref_primary_10_1002_pdi_2373
crossref_primary_10_55783__rcmf_160203
crossref_primary_10_3389_fmed_2021_760265
crossref_primary_10_1002_dmrr_3520
crossref_primary_10_1016_j_aprim_2021_102222
crossref_primary_10_3390_ijerph192215329
crossref_primary_10_1016_j_eimc_2022_10_002
crossref_primary_10_1016_j_aprim_2023_102588
crossref_primary_10_1016_j_aprim_2023_102702
crossref_primary_10_1016_j_diabres_2021_109127
crossref_primary_10_1080_20479700_2023_2225764
crossref_primary_10_5582_irdr_2023_01003
crossref_primary_10_1016_j_puhe_2023_02_017
crossref_primary_10_1186_s12875_023_02209_z
crossref_primary_10_47671_TVG_78_22_098
crossref_primary_10_1186_s12875_021_01471_3
crossref_primary_10_3390_electronics13081462
crossref_primary_10_55783_rcmf_140208
crossref_primary_10_1111_hiv_13180
crossref_primary_10_3389_fpubh_2023_1212584
crossref_primary_10_1186_s12875_022_01703_0
crossref_primary_10_3390_jcm11071752
crossref_primary_10_1136_bmjopen_2023_071828
crossref_primary_10_1542_peds_2023_063569
crossref_primary_10_1002_hsr2_1881
crossref_primary_10_2196_28629
crossref_primary_10_3389_fcdhc_2021_704807
crossref_primary_10_1016_j_aprim_2021_102233
crossref_primary_10_1016_j_vaccine_2022_04_016
crossref_primary_10_1093_ijcoms_lyab003
crossref_primary_10_1016_j_fmc_2020_11_003
crossref_primary_10_1093_eurpub_ckad224
crossref_primary_10_2196_40377
crossref_primary_10_3389_fpubh_2023_1116337
Cites_doi 10.1093/ehjqcco/qcaa034
10.1089/dia.2020.0184
10.1101/2020.04.17.20069716
10.1016/j.medcli.2012.01.020
10.25561/77482
10.1093/eurheartj/ehw106
10.1371/journal.pone.0109706
10.1016/j.jacc.2020.04.011
10.2807/1560-7917.ES.2020.25.6.2000094
10.1101/2020.04.24.20078550
10.1136/bmj.317.7169.1354
10.1186/s12911-019-0976-8
10.15585/mmwr.mm6919e2external
10.1001/jamahealthforum.2020.0588
10.1016/j.dsx.2020.03.014
10.1136/jclinpath-2020-206614
10.1016/S0212-6567
10.1007/978-3-540-74686-7
10.1186/2193-1801-2-51
10.1101/2020.05.04.20090050
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12875-020-01278-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2296
EndPage 9
ExternalDocumentID oai_doaj_org_article_11d2a8bfef1845258da5c64fc11d9340
PMC7547821
A638469217
33038926
10_1186_s12875_020_01278_8
Genre Journal Article
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GroupedDBID ---
23N
2WC
53G
5VS
6J9
6PF
AAFWJ
AAWTL
AAYXX
ABDBF
ACGFO
ACGFS
ACIHN
ACMJI
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBS
EMB
EMK
EMOBN
ESX
F5P
GROUPED_DOAJ
GX1
HYE
IAO
IHR
INH
INR
ITC
KQ8
M48
M~E
O5R
O5S
OVT
P2P
PGMZT
PQQKQ
PROAC
RBZ
RNS
ROL
RPM
SMD
SV3
TR2
TUS
U2A
UNMZH
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
K9.
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c563t-316f14b1a829981d7c0629a19a514bd983af1e49fcd9a6a287d8923a39d077713
IEDL.DBID M48
ISSN 1471-2296
IngestDate Wed Aug 27 01:32:27 EDT 2025
Thu Aug 21 13:54:47 EDT 2025
Fri Jul 11 16:58:05 EDT 2025
Mon Jun 30 12:45:32 EDT 2025
Tue Jun 17 21:38:44 EDT 2025
Tue Jun 10 20:30:40 EDT 2025
Mon Jul 21 06:03:57 EDT 2025
Tue Jul 01 00:58:14 EDT 2025
Thu Apr 24 22:54:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 1
Keywords Health Care
Chronic disease
Primary health care
Quaternary Prevention
Quality Indicators
COVID-19 [Supplementary Concept]
Quality Assurance, Health Care
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-316f14b1a829981d7c0629a19a514bd983af1e49fcd9a6a287d8923a39d077713
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8000-3321
OpenAccessLink https://www.proquest.com/docview/2451776214?pq-origsite=%requestingapplication%
PMID 33038926
PQID 2451776214
PQPubID 44667
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_11d2a8bfef1845258da5c64fc11d9340
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7547821
proquest_miscellaneous_2449993684
proquest_journals_2451776214
gale_infotracmisc_A638469217
gale_infotracacademiconefile_A638469217
pubmed_primary_33038926
crossref_citationtrail_10_1186_s12875_020_01278_8
crossref_primary_10_1186_s12875_020_01278_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-10-10
PublicationDateYYYYMMDD 2020-10-10
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-10
  day: 10
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC family practice
PublicationTitleAlternate BMC Fam Pract
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References MF Piepoli (1278_CR19) 2016; 37
1278_CR4
R Core Team (1278_CR16) 2018
1278_CR7
1278_CR18
1278_CR1
1278_CR3
M Garcia-Gil (1278_CR15) 2014; 9
D Andreas Moser (1278_CR6) 2020; 04
E Coma (1278_CR12) 2013; 2
1278_CR10
A McColl (1278_CR11) 1998; 317
E Coma (1278_CR25) 2019; 19
S Ghosal (1278_CR8) 2020; 14
B Bolíbar (1278_CR14) 2012; 138
D Prieto-Alhambra (1278_CR17) 2020; 05
E Coma Redon (1278_CR13) 2010; 6
RG White (1278_CR5) 2020; 04
S Bernard Stoecklin (1278_CR2) 2020; 25
E Vigliar (1278_CR9) 2020
1278_CR22
1278_CR23
1278_CR24
1278_CR20
1278_CR21
34257011 - Semergen. 2021 Oct;47(7):e49-e50
References_xml – ident: 1278_CR21
  doi: 10.1093/ehjqcco/qcaa034
– ident: 1278_CR7
  doi: 10.1089/dia.2020.0184
– volume: 04
  start-page: 20069716
  issue: 17
  year: 2020
  ident: 1278_CR6
  publication-title: MedRxiv
  doi: 10.1101/2020.04.17.20069716
– volume: 138
  start-page: 617
  year: 2012
  ident: 1278_CR14
  publication-title: Med Clin (Barc)
  doi: 10.1016/j.medcli.2012.01.020
– ident: 1278_CR3
  doi: 10.25561/77482
– ident: 1278_CR23
– volume: 37
  start-page: 2315
  issue: 29
  year: 2016
  ident: 1278_CR19
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehw106
– ident: 1278_CR1
– volume: 9
  start-page: e109706
  year: 2014
  ident: 1278_CR15
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0109706
– ident: 1278_CR20
  doi: 10.1016/j.jacc.2020.04.011
– volume: 25
  start-page: 2000094
  year: 2020
  ident: 1278_CR2
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2020.25.6.2000094
– volume: 04
  start-page: 20078550
  issue: 24
  year: 2020
  ident: 1278_CR5
  publication-title: MedRxiv
  doi: 10.1101/2020.04.24.20078550
– volume: 317
  start-page: 1354
  year: 1998
  ident: 1278_CR11
  publication-title: BMJ.
  doi: 10.1136/bmj.317.7169.1354
– volume: 19
  start-page: 245
  issue: 1
  year: 2019
  ident: 1278_CR25
  publication-title: BMC Med Inf Decis Making
  doi: 10.1186/s12911-019-0976-8
– ident: 1278_CR24
– ident: 1278_CR10
  doi: 10.15585/mmwr.mm6919e2external
– ident: 1278_CR22
  doi: 10.1001/jamahealthforum.2020.0588
– volume: 14
  start-page: 319
  issue: 4
  year: 2020
  ident: 1278_CR8
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2020.03.014
– volume-title: Cytology in the time of coronavirus disease (covid-19): an Italian perspective journal of clinical pathology published online first: 20
  year: 2020
  ident: 1278_CR9
  doi: 10.1136/jclinpath-2020-206614
– volume: 6
  start-page: 473
  issue: 8
  year: 2010
  ident: 1278_CR13
  publication-title: AMF.
– ident: 1278_CR18
  doi: 10.1016/S0212-6567
– volume-title: R software: Version 3.5.1. R Found Stat Comput Published Online First
  year: 2018
  ident: 1278_CR16
  doi: 10.1007/978-3-540-74686-7
– ident: 1278_CR4
– volume: 2
  start-page: 51
  issue: 1
  year: 2013
  ident: 1278_CR12
  publication-title: Springerplus.
  doi: 10.1186/2193-1801-2-51
– volume: 05
  start-page: 20090050
  issue: 04
  year: 2020
  ident: 1278_CR17
  publication-title: MedRxiv
  doi: 10.1101/2020.05.04.20090050
– reference: 34257011 - Semergen. 2021 Oct;47(7):e49-e50
SSID ssj0017822
Score 2.2179735
Snippet To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Retrospective study...
Background To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Methods...
To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care. Retrospective study...
To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care.BACKGROUNDTo analyse...
Abstract Background To analyse the impact of the COVID-19 epidemic and the lockdown measures on the follow-up and control of chronic diseases in primary care....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 208
SubjectTerms Adult
Analysis
Betacoronavirus
Chronic disease
Chronic diseases
Chronic illnesses
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
COVID-19
COVID-19 [Supplementary Concept]
Diabetes
Epidemics
Family medicine
Female
Health Care
Humans
Immunization
Male
Medical care quality
Middle Aged
Outcome Assessment, Health Care - statistics & numerical data
Pandemics - prevention & control
Patient care
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Primary care
Primary Health Care - organization & administration
Quality Assurance, Health Care
Quality control
Quality Indicators
Quality Indicators, Health Care
Quality of care
Quarantine - statistics & numerical data
Quaternary Prevention
Registries
Retrospective Studies
SARS-CoV-2
Socioeconomic factors
Spain
SummonAdditionalLinks – databaseName: DOAJ Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA_Sg3gRvx2tEkHwIEM3mUw-equrpQpVD1Z6C5lkgku7s8XdHvrH-r_4XpJZdhD04mmZyQubZH55H8n7IOR1bIMUPXqJd07Wog9t7ZwKtTLczZx2vWcY73z6WZ6ciU_n7flOqS_0CcvpgfPCHTAWuNNd7CPYIi1vdXCtlyJ6aDCNSNY6yLzRmCr3Byj3xhAZLQ_WwIUVRiKjExYHu0lPxFDK1v8nT94RSlOHyR0JdHyP3C2qIz3KQ75PbvXDA3L7tFyOPyS_vubMERS9uehioKDbUawdT1eRzr98__i-ZuaQLtMuxuO8RJAdOpAEn67wTHm58BR-0wuQdRcBLHW6zIeJa7oaaCNoDsa8wX7l7_DCB0v3wPMlOreCKktBI6Zca3q1O7IxMAso0X8UB5Lco6mkWAMJgEKzXzvOYZ6Ol4aFe0TOjj98m5_UpXpD7VvZbIC5y8hEx5wGiQdasfIzyY1jxoGO1gWjGxdZL0z0wTjp4AMFDdqma0yYKQW282OyN6yG_imhXTQc-EYXRGyE0l4DDoTXoumMj0L7irDxY1pfUptjhY1Lm0wcLW0GgAUA2AQAqyvydtunLMJfqd8hRraUmJQ7vQCo2gJV-y-oVuQNIswi64DheVciIGCSmITLHgEvFNKAkViR_QklbHk_bR4xagvLWVsuWqZAtDFRkVfbZuyJbnRDv7pGGjRwG6mB5kmG9HZKTYO5FrmsiJqAfTLnacuw-JESkitMCsfZs_-xSM_JHY77FJ2GZvtkb_Pzun8Bet-me5m2-G9S2FWL
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2gICMhcUBR14njBxdUFqqCVOBA0d4sx47Lim6ydLcHfiz_hRnHCRsh9bRKPNba8cx4Zvx5hpCXofKCN4gSr63IeeOr3Frpc6kLO7PKNo7hfeeTz-L4lH9aVIsUcNskWOWgE6Oi9p3DGPlBwSsmQXIZf7v-lWPVKDxdTSU0rpMbmLoMIV1yMTpcDHe_4aKMEgcb0MUS7yMjFKsA70lNNqOYs_9_zbyzNU1hkzv70NEdcjsZkPSwX_G75FrT3iM3T9IR-X3y52ufP4IiposuWwoWHsUK8rQLdP7l-8f3OdNv6CrKMgb1IkEP60ASfFpjZHm1dBR-4wvY8X568Nfpqg8pbmjX0pLT_krmb-yX_g6PfbCADzyfI8QVDFoKdjEtlKLr3ZEN17OAElGkOJAIkqaCYiUkYBfao9txDvMYZGqX9gE5PfrwbX6cpxoOuatEuQUVLwLjNbMK9j2wjaWbiUJbpi1YarXXqrSBNVwH57UVFhbIK7A5ban9TErwoB-SvbZrm8eE1kEXoD1qz0PJpXKqAufWKV7W2gWuXEbYsJjGpQTnWGfj3ERHRwnTM4ABBjCRAYzKyOuxT_oIV1K_Qx4ZKTE1d3zRXZyZJOnQ1xdW1aEJ4DzDEJW3lRM8OGjQJZ9l5BVymEEFAsNzNt2DgEliKi5zCBqRCw2uYkb2J5Qg-G7aPPCoSYpnY_6JSUZejM3YE8F0bdNdIg26uaVQQPOoZ-lxSmWJGRcLkRE5YfbJnKct7fJHTEsuMTVcwZ5cPayn5FaBEoigoNk-2dteXDbPwK7b1s-j8P4F0SZM_g
  priority: 102
  providerName: ProQuest
Title Primary care in the time of COVID-19: monitoring the effect of the pandemic and the lockdown measures on 34 quality of care indicators calculated for 288 primary care practices covering about 6 million people in Catalonia
URI https://www.ncbi.nlm.nih.gov/pubmed/33038926
https://www.proquest.com/docview/2451776214
https://www.proquest.com/docview/2449993684
https://pubmed.ncbi.nlm.nih.gov/PMC7547821
https://doaj.org/article/11d2a8bfef1845258da5c64fc11d9340
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3bbtMw1NpFQrwg7guMykhIPKBA4zi-IKFpK5sGUseEKOqb5dgJVLTpaDuJfSz_snOcpDRiQuIpSnyc2M652udCyIsy84IX6CWeWxHzwmextdLHUjPbt8oWLsF45-GZOB3xj-NsvEXackfNAi5vNO2wntRoMX396-fVARD8u0DwSrxZAo-VGGeMLlYMrCK1TXZBMkkk1CH_c6qA0jBEG8kkZkyLNojmxnd0BFXI5_83194QW12Xyg0ZdXKX3GmUS3pYY8M9slVU98mtYXN8_oD8Pq9zS1D096KTioL2R7G6PJ2XdPDp64f3caLf0lmgc9zwCwC1yweC4N0F7jrPJo7CNTwAafjDgy1PZ_V245LOK5pyWodrXmG_5nN4JITFfeB-iu6voOxS0JkpU4pebI6sDd0CSPQwxYEEB2oqKFZJAlSitec7zmEQNqCqiX1IRifHXwancVPfIXaZSFfA_kWZ8DyxCmQi6M3S9QXTNtEWtLjca5XaMim4Lp3XVlj4QV6BPmpT7ftSgnX9iOxU86rYIzQvNQPOknteplwqpzIwfJ3iaa5dyZWLSNL-TOOa5OdYg2NqghGkhKkRwAACmIAARkXk1bpPswj_hD5CHFlDYtru8GC--GYaLgB9PbMqL4sSDGsYovI2c4KXDhp0yvsReYkYZhDdYXjONjESMElM02UOgVtyocGMjMh-BxKYgus2tzhqWpoyjGeJBOGX8Ig8XzdjT3S0q4r5JcKgCZwKBTCPa5ReTylNMRsjExGRHWTvzLnbUk2-h5TlEtPGseTJfy3pU3KbIUGi_1B_n-ysFpfFM1ABV3mPbMux7JHdo-Oz88-9sJHSC7R-DXZpWVQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviG8CA4wE4gFFSxzHsZEQ2rpNLVvLhDa0N-PYCVSsSVk7Tfun-I_4X7jLR2mEtLc9VYnPrV2ff3dn3wchr_PYCZ6hl3hqhM8zF_vGJM5PFDOBkSazIcY7j8ZicMw_ncQna-R3GwuDbpUtJlZA7UqLZ-SbjMdhAjs35B9nv3ysGoW3q20JjZot9rPLCzDZ5h-GO7C-bxjb2z3qD_ymqoBvYxEtAHREHvI0NBKQGLS1xAaCKRMqA7pD6pSMTB5mXOXWKSMMWBROghZkIuWCJAGbDr73BlnnEZgyPbK-vTs-_LK8t0B524bmSLE5B_RPMAIanb8Y2GuyI_6qKgH_y4IVYdh11FyRfHt3yZ1GZaVbNY_dI2tZcZ_cHDWX8g_In8M6YwVFLzI6KSjolBRr1tMyp_3PX4c7fqje02mFHniMWBHUjiRIgk8zPMueTiyFz-oFyNifrrwo6LQ-xJzTsqARp3UQ6CX2a34OL5qwZBA8n6JTLajQFDRxyqSks9WRtQFhQIl-qziQyi2bCoq1l4BBae1Pj3PoV8daxcQ8JMfXsr6PSK8oi-wJoWmuGOBV6nge8URaGYM5bSWPUmVzLq1HwnYxtW1SqmNlj1NdmVZS6JoBNDCArhhAS4-8W_Zp_oQrqbeRR5aUmAy8elGefdcNtkBfx4xM8ywHcx2GKJ2JreC5hQYV8cAjb5HDNEIWDM-aJvICJonJv_QWYDAXCoxTj2x0KAFqbLe55VHdQN1c_9uYHnm1bMae6L5XZOU50qBhHQkJNI9rll5OKYowxyMTHkk6zN6Zc7elmPyoEqEnmIyOhU-vHtZLcmtwNDrQB8Px_jNym-FuRJekYIP0Fmfn2XPQKhfpi2YrU_LtutHjLwLjias
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Primary+care+in+the+time+of+COVID-19%3A+monitoring+the+effect+of+the+pandemic+and+the+lockdown+measures+on+34+quality+of+care+indicators+calculated+for+288+primary+care+practices+covering+about+6+million+people+in+Catalonia&rft.jtitle=BMC+family+practice&rft.au=Coma%2C+Ermengol&rft.au=Mora%2C+N%C3%BAria&rft.au=M%C3%A9ndez%2C+Leonardo&rft.au=Ben%C3%ADtez%2C+M%C3%A8ncia&rft.date=2020-10-10&rft.issn=1471-2296&rft.eissn=1471-2296&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1186%2Fs12875-020-01278-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12875_020_01278_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2296&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2296&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2296&client=summon